Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

Background: Neuroendocrine tumors (NETs) are rare tumors that can originate from any part of the body. Often,imaging or exploratory surgery can assist in the identification of the tumor primary site, which is critical to themanagement of the disease. Neuroendocrine tumors (NETs) of unknown primary constitute approximately 10-15%of all NETs. Determining the original site of the tumor is critical to providing appropriate and effective...